Myriad Genetics
MYGN
$18.50
Share price
-0.05%
Change (1 day)
-16.55%
Change (1 year)
P/S ratio for Myriad Genetics (MYGN)
P/S ratio as of April 2024 (TTM): 2.21
According to Myriad Genetics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.20869. At the end of 2023 the company had a P/S ratio of 2.28.
P/S ratio history for Myriad Genetics from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.28 | 31.43% |
| 2022 | 1.73 | -45.69% |
| 2021 | 3.19 | 94.46% |
| 2020 | 1.64 | -34.2% |
| 2019 | 2.49 | -6.58% |
| 2018 | 2.67 | -14.22% |
| 2017 | 3.11 | 104.91% |
| 2016 | 1.52 | -63.3% |
| 2015 | 4.14 | 23.16% |
| 2014 | 3.36 | 59.6% |
| 2013 | 2.11 | -48.18% |
| 2012 | 4.06 | 1.46% |
| 2011 | 4.00 | -26.66% |
| 2010 | 5.46 | -24.98% |
| 2009 | 7.28 | -8.76% |
| 2008 | 7.98 | -25.83% |
| 2007 | 10.8 | 14.13% |
| 2006 | 9.42 | 14.05% |
| 2005 | 8.26 | -22.13% |
| 2004 | 10.6 | 81.22% |
| 2003 | 5.86 | -11.36% |
| 2002 | 6.61 | -74.08% |
| 2001 | 25.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.55 | 106.19% | 🇺🇸 USA |
 Exact Sciences EXAS | 4.61 | 108.72% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 7.07 | 219.90% | 🇺🇸 USA |
 Biocept
BIOC | -0.3324 | -115.05% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 3.09 | 39.82% | 🇺🇸 USA |